NASDAQ$NVCR

Novocure Ltd · Q2 2019 earnings

Q2 2019 earnings · · Investor relations

Headline financials

Total Revenue

$86.7M

Previous: $61.5M+41.0%
EPS (adj)

-$0.01

Previous: -$0.17+94.1%
Total Active Patients

2.7K

No prior period
Capital Expenditures

-$892K

Previous: -$854K-4.4%
Free Cash Flow

-$2.16M

Previous: -$16.4M+86.8%
Net Income

-$1.27M

Previous: -$15.5M+91.8%
Operating Income

$1.2M

Previous: -$7.09M+116.9%
Gross Profit

$65.6M

Previous: $41.7M+57.4%
Cash & Equivalents

$180M

Previous: $114M+57.3%
Total Assets

$406M

Previous: $310M+31.1%
Stock-Based Comp

$13.7M

No prior period

Revenue & EPS history

Novocure · Revenue · Quarterly

$86.7M

Q2 2019+41%vs Q2 2018
Beat estimate in 8 of 16 quarters(50%)
ActualEstimate

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q2 2019

Historical avgQ2 2019

-0.5%

Avg return

Earnings day

+0.9%

Avg return

5 days after

+2.6%

Avg return

30 days after

49%

21 / 43 earnings

Positive

+27.5%

Q1 2026

Best reaction

-34.3%

Q2 2016

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+27.5%+33.1%+42.8%
Q4 2025-7.9%-11.3%-26.8%
Q3 2025-4.7%-11.0%-5.0%
Q2 2025-0.3%+3.9%+4.6%
Q1 2025+4.4%+2.9%+4.3%
Q4 2024-12.4%-17.2%-14.1%
Q3 2024-10.1%-1.8%+18.7%
Q2 2024+1.2%+24.2%-4.1%
Q1 2024+16.0%+21.9%+72.8%
Q4 2023-2.6%+4.4%-15.4%
Q3 2023-10.2%-5.5%-11.4%
Q2 2023-17.4%-19.1%-26.2%
Q1 2023+3.5%+6.2%+20.6%
Q4 2022-6.1%-6.1%-30.3%
Q3 2022+3.5%+8.1%+10.8%
Q2 2022-8.1%-5.1%+11.9%
Q1 2022-0.5%+8.9%+9.1%
Q4 2021+10.1%+10.5%+9.8%
Q3 2021-7.4%-2.8%-12.4%
Q2 2021-15.3%-18.0%-25.9%
Q1 2021-0.7%-4.0%-0.7%
Q4 2020-13.9%-11.6%-28.1%
Q3 2020+5.8%-1.4%+9.9%
Q2 2020+11.5%+14.9%+20.6%
Q1 2020-17.8%-12.8%-8.3%
Q4 2019-8.4%-12.7%-17.6%
Q3 2019+1.5%+4.3%+24.1%
Q2 2019+11.2%+17.3%+30.3%
Q1 2019+13.0%+10.0%+22.7%
Q4 2018+4.0%-2.5%-10.8%
Q3 2018-23.6%-22.9%-29.6%
Q2 2018-6.7%-9.2%+6.8%
Q1 2018+11.2%+14.3%+25.7%
Q4 2017-10.4%-1.9%+1.9%
Q3 2017+7.5%+19.3%+4.7%
Q2 2017+4.3%+2.3%+2.1%
Q1 2017+3.2%+8.2%+16.4%
Q4 2016-3.5%+6.3%-1.4%
Q3 2016+13.4%+21.8%+34.5%
Q2 2016-34.3%-31.6%-31.6%
Q1 2016+2.3%
Q4 2015+24.7%
Q3 2015+22.3%
Q1 2015
Q4 2014
Q3 2014
Q2 2014
Q1 2014

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro